Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Dong Kwon Keum
Introduction
Dong Kwon Keum is a notable inventor based in Daejeon, South Korea. He has made significant strides in the field of genetics and radiation research. His work focuses on the detection of DNA repair-related genes that respond to low-level radiation, which has important implications for cancer research and treatment.
Latest Patents
Dong Kwon Keum holds a patent for a detection method for DNA repair-related genes which respond to low-level radiation. This patent outlines a comprehensive process that includes breeding AKR/J mice, a thymus cancer model, alongside normal ICR mice in a low-dose radiation environment. The steps involve collecting thymuses from both mouse models, analyzing the genes present, and detecting DNA repair-associated genes that are expressed in both models. The final steps include amplifying the detected gene and measuring its expression level. This innovative method has the potential to advance our understanding of how low-level radiation affects genetic repair mechanisms.
Career Highlights
Keum is currently employed at Korea Hydro & Nuclear Power Company Ltd., where he applies his expertise in genetics and radiation. His work contributes to the company's mission of ensuring safety and efficiency in nuclear power generation. His dedication to research and innovation has positioned him as a valuable asset in his field.
Collaborations
Throughout his career, Dong Kwon Keum has collaborated with esteemed colleagues such as Hee Sun Kim and Hoon Moo Choi. These collaborations have fostered a productive research environment, leading to advancements in their shared field of study.
Conclusion
Dong Kwon Keum's contributions to the field of genetics and radiation research are noteworthy. His innovative detection method for DNA repair-related genes showcases his commitment to advancing scientific knowledge. His work not only enhances our understanding of genetic responses to radiation but also holds promise for future applications in cancer research.